Financial Services
AlipayHK launches blockchain cross-border remittance service
AlipayHK launches blockchain cross-border remittance service
The firm is tying up with Philippine-based micropayment service GCash.
Meituan Dianping hit by massive $22.79b loss ahead of blockbuster IPO
Ballooning market and research spending hit Meituan in its attempts to diversify.
Hong Kong could break into the top three IPO destinations by year-end
Total fundraising proceeds could hit $250b.
China Renaissance reportedly guns for US$800m in Hong Kong IPO
The investment bank is aiming for a valuation between US$4b to US$5b.
BOC (Hong Kong) to beef up private banking business by at least 20%
Given enough available talent, the bank aims to double the number of its relationship managers.
Xiaomi lays down terms for blockbuster IPO
The smartphone maker is said to offer 2.18 billion shares at $17 to $22 apiece.
Hang Seng Bank onboards SWIFT platform for faster cross-border payments
Payments can be credited within minutes.
Hong Kong can expect at least 15 more blockbuster IPOs in second half of the year
Around 10 unicorns or startups valued over US$1b are expected to debut in the city.
Xiaomi reportedly lowers valuation after delaying Mainland offering
The likely valuation of the smartphone maker is now between US$55b to US$70b.
Banks to hike prime rates by end-June
Tighter liquidity from mega IPOs will leave lenders with no other option.
Xiaomi to postpone Mainland share offering
The company may be aiming to complete its Hong Kong listing first.
Mainland lender Jiangxi Bank eyes $7.79b Hong Kong IPO
Citic Guoan Group and Dianrong are cornerstone investors.
Government launches Green Bond Grant Scheme
It subsidises green bond issuers in obtaining certification.
Hong Kong is the second largest offshore wealth center
It trails behind Switzerland after managing US$1.1t in offshore wealth.
Mainland online lender Lufax guns for US$2b fresh funding amidst IPO delay
It was originally planning to debut at the first half of 2018.
US biotech firm seeking larger valuations rush to Hong Kong
Sorrento Therapeutics is one such firm hoping to cash in on the trend.
US tightening buoys banking profitability
Funding costs are expected to stay low, boosting NIMs.
Read Here
Advertise
Sign Up
